Cisplatin as a radiation sensitizer in the treatment of advanced head and neck cancers. Results of a phase II study
β Scribed by Prakash B Chougule; Steve Suk; Quyen D. Chu; Louis Leone; Peter T. Nigri; Robert McRae; Mary Lekas; Anthony Barone; Dinesh Bhat; Joseph Bellino
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 552 KB
- Volume
- 74
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Piritrexim (PTX) is a newly developed lipid-soluble folate antagonist that crosses the cell membrane by a simple, rapid, carrier-independent diffusion process. A Phase II study was conducted to evaluate the activity of PTX in 34 patients with previously chemotherapy-naive squamous cell cancer of the
## Abstract ## Background The acute toxicity of intraoperative radiation therapy (IORT) delivered as an βearly boostβ after tumor resection in patients with locally advanced head and neck cancer was evaluated. ## Methods Twentyβfive patients were enrolled in the study. All patients underwent sur